Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
Jun 03 04:00PM ET
1.15
Dollar change
+0.05
Percentage change
4.24
%
Index- P/E- EPS (ttm)-0.23 Insider Own- Shs Outstand22.87M Perf Week-2.42%
Market Cap26.22M Forward P/E- EPS next Y- Insider Trans- Shs Float22.85M Perf Month42.79%
Income-5.28M PEG- EPS next Q- Inst Own1.20% Short Float0.06% Perf Quarter-11.80%
Sales2.25M P/S11.65 EPS this Y- Inst Trans-2.68% Short Ratio0.49 Perf Half Y34.89%
Book/sh0.23 P/B5.02 EPS next Y- ROA-91.68% Short Interest0.01M Perf Year242.27%
Cash/sh0.40 P/C2.85 EPS next 5Y- ROE-228.89% 52W Range0.25 - 2.90 Perf YTD54.95%
Dividend Est.- P/FCF- EPS past 5Y- ROI-101.03% 52W High-60.46% Beta0.16
Dividend TTM- Quick Ratio- Sales past 5Y49.58% Gross Margin8.43% 52W Low357.72% ATR (14)0.15
Dividend Ex-DateAug 01, 2018 Current Ratio- EPS Y/Y TTM25.33% Oper. Margin-711.67% RSI (14)60.34 Volatility11.79% 16.48%
Employees12 Debt/Eq0.07 Sales Y/Y TTM-87.44% Profit Margin-234.88% Recom- Target Price-
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q40.33% Payout- Rel Volume0.43 Prev Close1.10
Sales Surprise-7.88% EPS Surprise350.00% Sales Q/Q25.47% Earnings- Avg Volume29.33K Price1.15
SMA2029.33% SMA5019.83% SMA2004.74% Trades Volume12,688 Change4.24%
Akso Health Group operates a social e-commerce platform principally in China that collaborates with other domestic e-commerce platforms and offers users a wide selection of products. It also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider with operations in the U.S. The firm plans to open 2 vaccine research centers and 100 radiation oncology centers to be located on the east coast serving cancer patients in need of varying stages of treatment, including specialized radiation therapy centers for radiotherapy, personalized consultation, conventional treatment planning, and other cancer related treatment services. The company was founded by Xiaobo An in March 2014 and is headquartered in Beijing, China.